Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Christian Henry, Mike Hunkapiller, Karen Tay Koh, Michael Vounatsos, More

Pacific Biosciences: Christian Henry, Mike Hunkapiller, William Ericson
Pacific Biosciences has appointed Christian Henry to serve as chairman of its board of directors, effective immediately.
PacBio said in a statement it was separating the chairman and CEO roles "in alignment with best practices." Mike Hunkapiller, the previous chairman, will continue to serve as president and CEO and will remain on the board. William Ericson of Wildcat Venture Partners will step down as lead independent director but will also continue to serve on the board.
Henry was previously executive VP and chief commercial officer at Illumina. He joined the board in July 2018.
PacBio will provide Henry an annual retainer of $35,000 as well as options to purchase 35,000 shares of common stock.
BC Platforms: Karen Tay Koh
BC Platforms has named Karen Tay Koh to its board of directors. A former deputy CEO of the publicly owned Singapore Health Services provider network, Koh is a senior advisor to Dubai-based private equity firm TVM Capital Healthcare Partners and sits on numerous other boards, including that of Danish emergency medical firm Falck. BC Platforms said that she will work closely with the company's newly established Singapore office to serve the Asia-Pacific region.
PerkinElmer: Michel Vounatsos
PerkinElmer has appointed Michel Vounatsos to its board of directors, effective March 1. He is currently CEO of Biogen. Before that, he was at Merck, where he held several leadership positions, including president of the Primary Care Customer Business Line and Merck Customer Centricity. Earlier in his career, he held management positions at Ciba-Geigy.
For additional recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.